Jaydutt Patel, MD, Discusses Tilt Table Tests

Tilt table tests examine possible conditions of the autonomic nervous system. The simple test has the patient lie down on a horizontal table that has supports for the feet. The table then rises by small degrees until it assumes a vertical position, effectively moving the patient from a lying to a standing position. During the test, various devices monitor the patient’s pulse and blood pressure. Physicians encourage the patient to report any symptoms or discomfort experienced during the tilt table test. These symptoms may include nausea, sweating, bodily weakness, or dizziness. All of these symptoms provide the practitioner with valuable insight into the cause of the patient’s problem. Physicians generally recommend that patients undergo the test after complaining of bouts of lightheadedness, nausea, or fainting. Primarily, doctors use the tilt table test to rule out or confirm postural hypotension as the root of fainting attacks.

As a person stands, blood naturally rushes to the feet due to gravity. Normally, nerves in the legs constrict blood vessels to compensate for the pooling, ensuring the heart continues to receive enough blood to deliver oxygen to the rest of the body. When an individual suffers from postural hypotension, the nerves fail to constrict the blood vessels, diminishing the amount of blood available for circulation and ultimately depriving the brain of oxygen. The individual thus experiences lightheadedness and even fainting. Heart disease may also cause bouts of fainting, making the tilt table test a valuable, inexpensive, and noninvasive method of ruling out underlying heart problems.

As a consultant at Pennsylvania’s Saint Vincent Health System, Jaydutt Patel, MD, specializes in the treatment of cardiovascular disorders. After graduating from the PramukhSwami Medical College in the top five percent of his class, he traveled to the United States to complete his residency in internal medicine. Jaydutt Patel, MD, later decided to specialize in cardiovascular medicine and cardiac electrophysiology, pursuing fellowships at Caritas St. Elizabeth’s Medical Center, a Tufts University School of Medicine affiliate, and Brigham and Women’s Hospital, a Harvard Medical School affiliate.


About Dr. Jaydutt Patel MD

As one of 11 heart specialists known collectively as Consultants in Cardiovascular Diseases, Inc. (CICDI), Dr. Jaydutt Patel serves on an elite team of physicians with a high level of expertise in diagnosis of and intervention in cardiac conditions. Located in Erie, Pennsylvania, Dr. Jaydutt Patel and his colleagues perform in-office nuclear cardiac testing and echocardiography, with a lab fully accredited by the Intersocietal Commission for Accreditation of Echocardiography Laboratories. Among other heart-related conditions, Dr. Jaydutt Patel treats ventricular and supraventricular arrhythmias at CICDI. Arrhythmia, or abnormal beating of the heart, typically poses a danger because it results in lower levels of blood transport to the rest of the body. Ventricular simply refers to problems in the heart’s two lower chambers, and supraventricular to those that occur in the upper chambers. Catheter ablation, another area of expertise for Dr. Jaydutt Patel, consists of inserting an electrode catheter, a long, thin, flexible wire, into the heart and sending heat through it. This procedure enables a skilled cardiac electrophysiologist such as Dr. Jaydutt Patel to reach and destroy an abnormal electrical pathway that causes heart arrhythmia. Trained heart physicians such as Dr. Patel may implant a pacemaker or defibrillator to solve heart-rate problems. A pacemaker speeds up a habitually slow heartbeat and a defibrillator tends to return an abnormally fast heartbeat to a more normal pace. Dr. Jaydutt Patel has training and experience with placement and removal of both devices. Dr. Patel has demonstrated particular expertise with the Implantable Cardioverter-Defibrillator (ICD): he co-authored an article titled “ICD Implantation in Patients with Ischemic Left Ventricular Dysfunction,” which appeared in the February 2009 issue of the journal Current Treatment Options in Cardiovascular Medicine. Dr. Patel’s article considers implantable cardioverter-defibrillator therapy as a tool for recognizing patients who have an increased potential for sudden and fatal cardiac arrest and who would likely benefit from ICD therapy.
This entry was posted in Uncategorized and tagged , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s